10:27 AM EST - Medicenna Therapeutics Corp. : Has received conditional approval from the Toronto Stock Exchange to extend the expiry date of the common share purchase warrants of the Company originally issued on October 17, 2019. The Warrants, of which 1,549,052 are available to be extended, are exercisable for common shares of the Company at a price of $1.75 per Common Share and are set to expire on October 17, 2022. Medicenna Therapeutics Corp.
shares T.MDNA are trading unchanged at $1.10.
